pre-seed
Stage
About
Pumpinheart is developing the PReduction device, an ECG-gated implantable diastolic pump implanted via transcatheter to reduce left atrial pressure and treat patients with Heart Failure with preserved Ejection Fraction (HFpEF). The device is designed for cath lab delivery and aims to improve outcomes and reduce hospitalizations for advanced HFpEF patients.
Explore Pumpinheart's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.